Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TransMedics (TMDX) Gross Profit (2018 - 2025)

TransMedics has reported Gross Profit over the past 8 years, most recently at $93.4 million for Q4 2025.

  • Quarterly results put Gross Profit at $93.4 million for Q4 2025, up 29.72% from a year ago — trailing twelve months through Dec 2025 was $362.8 million (up 38.43% YoY), and the annual figure for FY2025 was $362.8 million, up 38.43%.
  • Gross Profit for Q4 2025 was $93.4 million at TransMedics, up from $84.6 million in the prior quarter.
  • Over the last five years, Gross Profit for TMDX hit a ceiling of $96.6 million in Q2 2025 and a floor of $3.8 million in Q3 2021.
  • Median Gross Profit over the past 5 years was $38.7 million (2023), compared with a mean of $43.3 million.
  • Biggest five-year swings in Gross Profit: dropped 25.11% in 2021 and later skyrocketed 380.12% in 2022.
  • TransMedics' Gross Profit stood at $7.0 million in 2021, then surged by 196.35% to $20.7 million in 2022, then skyrocketed by 131.48% to $47.9 million in 2023, then skyrocketed by 50.27% to $72.0 million in 2024, then rose by 29.72% to $93.4 million in 2025.
  • The last three reported values for Gross Profit were $93.4 million (Q4 2025), $84.6 million (Q3 2025), and $96.6 million (Q2 2025) per Business Quant data.